| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | -49.3% |
| R&D Expense | $3.2M | -30.2% |
| SG&A Expense | $1.6M | -57.8% |
| Operating Income | -$113.2M | -158.1% |
| Interest Expense | $7.9M | +911.8% |
| Pre-tax Income | -$1.14B | -2226.3% |
| Income Tax | $287K | +0.2% |
| Net Income | -$1.14B | -2212.8% |
| EPS (Basic) | -$18.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | +64.7% |
| Short-term Investments | $1K | -100.0% |
| Accounts Receivable | $2.9M | -3.3% |
| Current Assets | $24.1M | -6.0% |
| Total Assets | $50.6M | -24.0% |
| Current Liabilities | $295.7M | +518.2% |
| Total Liabilities | $296.5M | +407.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.0M | +31.3% |
| Capital Expenditures | $105K | +0.1% |
| Investing Cash Flow | $3.7M | -65.3% |
| Financing Cash Flow | $24.0M | +2412.3% |
| Free Cash Flow | -$29.1M | +31.2% |
| -2310.7% |
| EPS (Diluted) | -$18.08 | -2310.7% |
| Stockholders' Equity |
| -$246.0M |
| -3135.6% |